NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort

Baseline NT-proBNP in COPD is an independent predictor of respiratory exacerbations, even in individuals without overt cardiac disease. The impact of detection and treatment of early cardiovascular dysfunction on COPD exacerbation frequency warrants further investigation.